Background and purpose: Body Mass Index (BMI) is known to be an independent risk
BACKGROUND
Obesity has been increasing in large proportions over the last decades. The prevalence of overweight in Europe ranges between 32% and 79% in men and between 28% and 78% in women; and the prevalence of obesity ranges between 5% and 23% in men and between 7% and 36% in women (1) .
Albania has the highest prevalence of overweight and obesity in Europe ranging around 58% and 22% respectively in men and 40% and 36% respectively in women respectively (1) .
Obesity affects the cardiovascular system in different ways -affecting hemodynamics, structure and function (2) , as well as increasing the prevalence of heart failure (3), atrial fibrillation (4), coronary artery disease (CAD) (5) . BMI is known to be an independent risk factor for hypertension (6) (7) , type 2 diabetes mellitus (8) , dyslipidemia (2, 9) . The influence of obesity on such risk factors and also on inflammatory mark-ORIGINAL PAPER | MEd ARh. 2015 dEc; 69(6): 396-399 ers and prothrombotic state (10) predisposes for more extensive coronary atherosclerosis.
The aim of our analysis was to evaluate the differences among BMI groups on demographic, angiographic and procedural findings in patients undergoing their first elective percutaneous coronary intervention (PCI).
METHODS

Data Sources
All consecutive patients, who underwent their first elective PCI procedures from September 2011 to December 2013 were enrolled in the study. Patients who had previously undergone PCI or coronary artery by-pass grafting (CABG) and who underwent primary procedures for coronary acute syndromes were excluded from the study. At the same time, patients with BMI <18.5 or >50 kg/m2 were excluded. The remaining patients comprised the study cohort. Based on these selection criteria, 781 patients were enrolled in the study.
Definitions
BMI was calculated as body weight (kg) divided by the square of the height (m). Weight was categorized as normal weight (BMI 18.5 -24.9 kg/m2), overweight (25 -29.9 kg/m2), obese (≥ 30kg/m2).The patients were divided into these 3 groups according to each BMI categories.
The extent of coronary artery disease was classified according to the number of coronary arteries with significant (> 50%) stenoses, one, two, or three vessel disease or left main stenosis (> 50%). High risk anatomy was defined as either three vessel disease or left main stenosis.
Hypertension was defined as blood pressure ≥ 140/90 mmHg or under antihypertensive therapy. Dyslipidemia was defined as Total cholesterol ≥ 200 mg/dL, LDL ≥ 150 mg/dL, HDL ≤ 40 mg/dL and Triglycerides ≥ 150 mg/dL or under hypolipemiant therapy.
Diabetes mellitus was defined as fasting glucose level ≥126mg/dL and load glucose level ≥ 180 mg/dl or under therapy for known diabetes mellitus.
We also studied previous family history of CAD, smoking, previous myocardial infarction, left ventricular (LV) impairment (EF < 50%), renal function impairment (seric creatinine >1.4 mg/dl), medical treatment, type of vessel treated, number of vessels treated/person, number, length and diameter of stents/person.
Statistical Analyses
Demographic characteristics, angiographic and procedure related variables were summarized using mean ± SD for continuous variables compared using t tests and frequency and percentage for categorical variables compared using chi-squared (χ2) tests. Statistical significance was set at p≤ 0.05 
Angiographic and procedural fi ndings
Patients who were selected for PCI were predominantly 1-vessel CAD in all BMI groups (51.9% vs. 50.6% vs. 49.3%) without statistically signifi cant diff erences. Obese patients had a higher risk anatomy (3-vessel CAD + LM) compared to normal weight individuals, but it was not statistically signifi cant (18.8% vs. 14.2% p=0.25). (Table  2) .
In all groups, the left anterior descending artery (LAD) was the vessel treated most often, with no signifi cant diff erence between groups (59.2% vs. 60.7% vs. 58.7%) Th ere was also no diff erence between groups in the treatment of the left circumfl ex (LCX) and right coronary artery (RCA).
Th ere was no diff erence among BMI groups in the number of vessels treated per person (1.25±1.17 vs. 1.3±0.49 vs. 1.28±0.49).
Compared to normal weight patients, obese patients have a higher number of stents/person used (1.95±1.17 vs. 1.685±0.91 p=0.014), a higher length of stents/person used (36.67±22.02 vs. 31.7±17.48 p=0.016), and also a larger stent diameter (3.14±0.4 vs. 2.98±0.33 p=0.0001).
DISCUSSION
It is well-known that obesity is an independent risk factor for serious health conditions, including diabetes mellitus, hypertension and dyslipidemia (6) (7) (8) (9) (10) . In our study we documented that obese individuals undergoing percutaneous coronary intervention have various diff erences in baseline demographics on presentation compared to normal individuals. Obese patients are younger, presenting with CAD earlier in time than normal weight patients. Obese patients undergoing PCI, in accordance with many other studies (11, 12, 13) , are more likely to have diabetes, dyslipidemia and hypertension, infl uencing directly to more extensive coronary artery disease . (Figure 1) .
In a recent study Kang et al. (14) showed that a higher BMI was associated with a larger plaque area and a greater plaque burden. Our study indirectly supports the existence of more extensive coronary disease in obese individuals based on the higher length of stents/person used in each procedure.
Obesity is characterized by the increase of fi lling pressure and volume leading to a left ventricular chamber dilatation and hypertrophy (2), which is correlated to an increased coronary lumen diameter (15) . Dilated coronary lumen can also result during arterial remodeling because of the atherosclerosis process. Kang et al (14) also showed that the higher BMI group had a larger external elastic membrane area and volume (positive remodeling) indicating a greater compensatory response to plaque accumulation that preserves lumen area and volume. Th is larger lumen area allows the use of larger stents. In our study the diameter of stents/person used in obese individuals was larger than in normal ones, just as it resulted in the Des-DE study (11) .
Th e use of CCBs and ACEIs/ARBs is greater in obese patients, probably related to a higher prevalence of hypertension in these patients.
CONCLUSIONS
Patients with a higher BMI are younger and have diabetes mellitus, hypertension and dyslipidemia more frequently. Th e patients of the higher BMI group have a greater length and diameter of stents used, probably related to a more extensive coronary artery disease. Further studies are needed to investigate the impact of obesity on the outcomes in patients undergoing percutaneous coronary intervention.
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